Aptose Biosciences Inc. Banner Image

Aptose Biosciences Inc. has reached its limit for free report views

Work for Aptose Biosciences Inc.? Upgrade Your Profile and unlock all your annual reports.

Aptose Biosciences Inc.

  • Ticker APS
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
Aptose Biosciences Inc. Logo Image
  • 11-50 Employees
  • Based in Mississauga, Ontario
Aptose Biosciences is a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS) and other hematologic malignancies. Based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, Aptose is building a pipeline of novel oncologyMore therapies directed at dysregulated processes and signaling pathways. Aptose is developing targeted medicines for precision treatment of these diseases, based on a patient’s specific gene expression signature. In the treatment of cancer, this strategy is intended to optimize efficacy and quality of life by minimizing the cytotoxic side effects associated with conventional therapies.
Aptose Biosciences Inc.

Most Recent Annual Report

Aptose Biosciences Inc. MOST RECENT 2019 Annual Report

Report Locked. Aptose Biosciences Inc. has reached its limit for free report views.

Older/Archived Annual Reports